andrew kline Resources | BNET
On CBS.com: Charlie gets in touch with his feelings

Resources

1 Resources for

andrew kline

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Andrew Kline: Investing in Sports
Looking for a niche in a big, competitive field? Andrew Kline has done just that. As senior managing director of investment bank Park Lane, the former offensive lineman for the St. Louis Rams advises corporations and high net worth individuals who are looking to buy and sell properties in the...
Tags: niche business, Football, Sports investment, Finance, Andrew Kline, Investment, Financial Services
Videos 2007-11-13

Additional Resources

GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
LONDON, July 23 /PRNewswire-FirstCall/ -- In a video interview, new CEO Andrew Witty comments on GSK's second quarter results while also updating the market on his strategic vision for the business. The new strategic priorities for GlaxoSmithKline are: - Grow a diversified global business -...
Articles 2008-07-23
Business Digest
Anglo American sells South African stakes *Anglo American's South African operations completed seven deals to sell stakes to black groups worth 50bn rand (3.3bn) in 2007, the miner said yesterday. Anglo, the lead investor in South Africa with interests in platinum, coal, iron...
Articles 2008-07-09
Pepper Hamilton Top-Ranked in Commercial Litigation in Pennsylvania; Nationally Ranked in Products Liability and Transportation
Chambers USA: America's Leading Lawyers for Business Highly Rates Eight Practices and 29 Lawyers Based on Client Interviews and Independent Research PHILADELPHIA -- Pepper Hamilton LLP's commercial litigation practice is ranked as one of the two best in Pennsylvania, and the firm's products liability and...
Articles 2008-07-01
Glaxo in Pounds 170m drugs sale to South Africa
Business News IN BRIEF *GlaxoSmithKline, the UK's biggest drugs company, announced yesterday that it has sold off a number of its treatments to the South African pharmaceutical group Aspen Global. The sales of Eltroxin, Lanoxin, Imuran and Zyloric will raise 170m. GSK's chief...
Articles 2008-07-01
The $50+ Million Club
AUM $ FIRM NAME CITY STATE MANAGING PARTNER 99,000,000 Mason Road Wealth Advisors St. Louis MO William J. Bender98,838,366 Gunn & Company Investment Management Jacksonville FL Marshall D. Gunn, Jr.93,573,143 ShankerValleau Evanston IL Larry Shanker, John Valleau93,000,000 Shinn Financial Group Fort Collins CO Ralph T. Shin91,000,000 PKS Investment...
Articles 2008-07-01
Cytokinetics Announces Clinical Data Regarding Ispinesib in Combination With Capecitabine
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the results of a Phase Ib clinical trial designed toevaluate ispinesib in combination with capecitabine, an oral chemotherapyagent commonly used in the treatment of breast cancer. Ispinesib is anovel, small molecule inhibitor of kinesin spindle protein KSP, a mitotickinesin essential for...
Articles 2008-06-30
Focalyst Executive Forum 2008, October 2-3, NYC
Millward Brown to Host Over 60 Leading Marketers and Experts Sharing Emerging Trends on Where the Boomer Market is Headed NEW YORK -- Focalyst WHAT: Focalyst Executive Forum: New Insights for Marketers Targeting Boomers and Beyond Despite knowing the size, spending...
Articles 2008-06-27
Rearden Commerce and American Express Launch New Mobile Service to Simplify Work and Life for Business Travelers
FOSTER CITY, Calif., and NEW YORK, June 24 /PRNewswire-FirstCall/ -- Rearden Commerce, Inc., and American Express today announced American Express AnywhereSM, an innovative new mobile service that enables corporate customers to manage travel details and business through their BlackBerryTM smartphones. With a single...
Articles 2008-06-24
For Executives on the Go, Emptoris Offers Supply and Contract Management Insights in New Podcast Series
Emptoris , a leading provider ofenterprise supply and contract management software, today launched the Emptoris PodcastNetwork, a series of recorded conversations with experts from a range ofdisciplines designed to help busy executives get quick insights intostrategic procurement and contracting issues. The first...
Articles 2008-06-23
Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
NEW YORK, June 17 /PRNewswire/ -- Among US primary care physicians, Novartis earns the highest sales rep relationship scores, followed by Pfizer, Merck, GlaxoSmithKline and Sanofi-Aventis, according to new research from TNS Healthcare. Novartis also takes the top spot in Europe, demonstrating a consistent ability...
Articles 2008-06-17
Emptoris Placed in Top Tier of Spend Analysis Providers in New Independent Research Report
Emptoris , a leading provider ofenterprise supply and contract management software, today announced that Forrester Research,a leading independent research and analysis firm, has reviewed EmptorisSpend Analysis in an April 2008 report titled, "Market Overview 2008:Automated Spend Analysis." The report reviews 12 spend analysis...
Articles 2008-06-16
GSK is wrong treatment for credit crunch ailment
THE INVESTMENT COLUMN Our view: Sell Share price: 1053p (-11p) By drug giant GlaxoSmithKline's own admission, this financial year will not be the shot in the arm that investors might have been hoping for as earnings will...
Articles 2008-06-12
Glaxo cutting research jobs
Scientists and other research workers at GlaxoSmithKline P.L.C.'s King of Prussia and Collegeville facilities are getting their pink slips this week. The British drugmaker, which has a U.S. headquarters in Philadelphia, is cutting 2 percent of its 17,000 global research-and-development employees, or about 350, with about half of them...
Articles 2008-06-12
Cytokinetics to Present Clinical Data on CK-1827452, a Selective Cardiac Myosin Activator, at the 2008 Heart Failure Congress of the European Society of Cardiology
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that interim results from an ongoing Phase IIaclinical trial in stable heart failure patients evaluating CK-1827452, anovel cardiac myosin activator being developed for the potential treatmentof patients with either acutely decompensated or chronic heart failure, arescheduled to be presented as part of...
Articles 2008-06-09
MANUFACTURERS
Traversa Therapeutics appointed Barry Toyonaga, PhD, to the position of SVR business development. Toyonaga joins Traversa with over 20 years of experience with biotech, pharmaceutical and venture capital firm including Johnson & Johnson and Ontogen. Neuromed Pharmaceuticals has announced the promotion of Sean Cunliffe to chief commercial officer....
Articles 2008-06-01
New GSK boss reshuffles his top team
Business News IN BRIEF *GlaxoSmithKline's incoming chief executive Andrew Witty took the first step to stamp his authority on the top level of management yesterday by reshuffling the group's senior team. Mr Witty, who takes over from Jean-Pierre Garnier on 22 May, announced the creation of new...
Articles 2008-05-01
School nutrition debated by house.(WASHINGTON)
On Mar. 4, the House Committee on Education and Labor held a hearing entitled "Challenges and Opportunities for Improving School Nutrition." This hearing was summarized by THE FOOD INSTITUTE Counsel, OLSSON FRANK WEEDA TERMAN BODE MATZ PC. Chairman Miller (D-CA) and Ranking Member McKeon (R-CA) presided...
Articles 2008-03-10
Southpaws must improve
SCOTTSDALE, Ariz. -- The San Francisco Giants were disappointed in their left-handed relievers last season, so it's no surprise that Jack Taschner and Steve Kline face plenty of competition this spring. The group includes two pitchers the Giants are almost certain to lose if they don't...
Articles 2008-02-16
Trends in holistic beauty and nutraceuticals: trends in holistic beauty are spurring the nutricosmetic segment and recent product launches.(Nutricosmetics)
[ILLUSTRATION OMITTED] Consumers expect cosmetics and toiletries to offer health and well-being benefits in addition to beauty benefits, and use products for the mind as much as for the body. The beauty benefit of what is ingested is now considered...
Articles 2008-02-01
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement